Kidney cancer study reveals muscle loss clues in 161 patients
NCT ID NCT06898632
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looked at how lifestyle factors like obesity and muscle loss affect kidney cancer risk and survival after kidney removal. Researchers collected blood, tissue, and questionnaire data from 161 patients over up to 5 years. The goal was to understand how to personalize treatments and improve health after diagnosis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
161 people
The number who actually took part.
- Started
-
Mar 2021
- Finished
-
Jan 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients presenting to clinic 2B at the Huntsman Cancer Hospital
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Renal Cell Cancer (RCC) stage I-IV * Undergoing radical nephrectomy (entire kidney resection) or partial nephrectomy * Patients with or without prior systemic therapy for renal cell carcinoma and \> 1 year from systemic therapy for other non-cutaneous malignancy * Cytoreductive nephrectomy (nephrectomy in the setting of limited metastatic disease) Exclusion Criteria: * Does not consent to tissue collection * Patients with only an MRI abdomen/pelvis within 4 months of surgery will be excluded * Known biopsy-proven non-clear cell RCC
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Kidney cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug target Hard-to-Treat kidney and ovarian cancers?
- Personalized dosing could tame kidney cancer Drug's side effects
- Can a coordinated care team reduce severe side effects in older cancer patients?
- Can a new antibody help the immune system fight Hard-to-Treat tumors?
- Can teaching patients about immunotherapy cut severe side effects?
- Can a year of sunitinib delay kidney Cancer's return after lung surgery?